Sára Eszter Pál

Ms. Sára Eszter Pál


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Journal of Environmental Radioactivity
Verified
Journal Article
Closed access
NENóra Tünde Enyedi
Nóra Tünde Enyedi
DADóra Anda
Dóra Anda
ABAndrea K Borsodi
Andrea K Borsodi
ASAttila Károly Szabó
Attila Károly Szabó
SPSára Eszter Pál
Sára Eszter Pál
JMJudit Makk
Judit Makk

29 January 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
SPSára Eszter Pál
Sára Eszter Pál
RTRenáta Tóth
Renáta Tóth
Joshua D NosanchukJoshua D Nosanchuk
Joshua D Nosanchuk
CVCsaba Vágvölgyi
Csaba Vágvölgyi
TNTibor Nemeth
Tibor Nemeth
AGAttila Gacser
Attila Gacser
Relative to the vast data regarding the virulence mechanisms of Candida albicans, there is limited knowledge on the emerging opportunistic human pathogen Candida parapsilosis. The aim of this study was to generate and characterize an overexpression mutant collection to identify and explore virulence factors in C. parapsilosis. With the obtained mutants, we investigated stress tolerance, morphology switch, biofilm formation, phagocytosis, and in vivo virulence in Galleria mellonella larvae and mouse models. In order to evaluate the results, we compared the data from the C. parapsilosis overexpression collection analysis to the results derived from previous deletion mutant library characterizations. Of the 37 overexpression C. parapsilosis mutants, we identified eight with altered phenotypes compared to the controls. This work is the first report to identify CPAR2_107240, CPAR2_108840, CPAR2_302400, CPAR2_406400, and CPAR2_602820 as contributors to C. parapsilosis virulence by regulating functions associated with host-pathogen interactions and biofilm formation. Our findings also confirmed the role of CPAR2_109520, CPAR2_200040, and CPAR2_500180 in pathogenesis. This study was the first attempt to use an overexpression strategy to systematically assess gene function in C. parapsilosis, and our results demonstrate that this approach is effective for such investigations.

14 September 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
PBPéter Bacsur 
Péter Bacsur 
TRTamás Resál
Tamás Resál
BFBernadett Farkas
Bernadett Farkas
BJBoldizsár Jójárt
Boldizsár Jójárt
ZGZoltán Gyuris
Zoltán Gyuris
ABAnita Bálint
Anita Bálint
Alterations to intestinal microbiota are assumed to occur in the pathogenesis of inflammatory bowel disease (IBD). This study aims to analyze the association of fecal microbiota composition, body composition, and lipid characteristics in patients with Crohn’s disease (CD). In our cross-sectional study, patients with CD were enrolled and blood and fecal samples were collected. Clinical and endoscopic disease activity and body composition were assessed and laboratory tests were made. Fecal bacterial composition was analyzed using the shotgun method. Microbiota alterations based on obesity, lipid parameters, and disease characteristics were analyzed. In this study, 27 patients with CD were analyzed, of which 37.0% were obese based on visceral fat area (VFA). Beta diversities were higher in non-obese patients (p < 0.001), but relative abundances did not differ. C. innocuum had a higher abundance at a high cholesterol level than Bacillota (p = 0.001, p = 0.0034). Adlercreutzia, B. longum, and Blautia alterations were correlated with triglyceride levels. Higher Clostridia (p = 0.009) and B. schinkii (p = 0.032) and lower Lactobacillus (p = 0.035) were connected to high VFA. Disease activity was coupled with dysbiotic elements. Microbiota alterations in obesity highlight the importance of gut microbiota in diseases with a similar inflammatory background and project therapeutic options.